Mitochondrial dysfunction: Cause and consequence of alzheimer's disease

Progress in Molecular Biology and Translational Science

Volumn 127, Issue , 2014, Pages 183-210

  Friedland Leuner, Kristina ^a   Stockburger, Carola ^b   Denzer, Isabel ^a   Eckert, Gunter P ^b   Müller, Walter E ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Fission; Fusion; mtDNA; Reactive oxygen species; Respiratory chain

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E4; DIMEBON; FLAVONOID; GINKGO BILOBA EXTRACT; POLYPHENOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TAU PROTEIN;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN AGING; BRAIN DEGENERATION; COGNITIVE DEFECT; DEVELOPMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EX VIVO STUDY; GINKGO BILOBA; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; RISK FACTOR; ANIMAL; BRAIN; METABOLISM; MITOCHONDRION; PATHOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; HUMANS; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION;

EID: 84906666540     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394625-6.00007-6     Document Type: Chapter

References (160)

1. A.M. Stranahan, and M.P. Mattson Recruiting adaptive cellular stress responses for successful brain ageing Nat Rev Neurosci 13 3 2012 209 216 10.1038/nrn3151
2. D. Kapogiannis, and M.P. Mattson Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease Lancet Neurol 10 2 2011 187 198 10.1016/S1474-4422(10)70277-5
3. M.D. Brand, a.L. Orr, I.V. Perevoshchikova, and C.L. Quinlan The role of mitochondrial function and cellular bioenergetics in ageing and disease Br J Dermatol 169 Suppl 2013 1 8 10.1111/bjd.12208
4. G.E. Gibson, A. Starkov, J.P. Blass, R.R. Ratan, and M.F. Beal Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases Biochim Biophys Acta 1802 1 2010 122 134 10.1016/j.bbadis.2009.08.010
5. M. Morán, D. Moreno-Lastres, L. Marín-Buera, J. Arenas, M.a. Martin, and C. Ugalde Mitochondrial respiratory chain dysfunction: implications in neurodegeneration Free Radic Biol Med 53 3 2012 595 609 10.1016/j.freeradbiomed.2012.05.009
6. M. Frenzel, H. Rommelspacher, M.D. Sugawa, and N.A. Dencher Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex Exp Gerontol 45 7-8 2010 563 572 10.1016/j.exger.2010.02.003
7. A. Navarro, J.M. López-Cepero, and M.J. Bández et al. Hippocampal mitochondrial dysfunction in rat aging Am J Physiol Regul Integr Comp Physiol 294 2 2008 R501 R509 10.1152/ajpregu.00492.2007 (Pubitemid 351213756)
8. A. Navarro, and A. Boveris Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging Am J Physiol Regul Integr Comp Physiol 287 5 2004 R1244 R1249 10.1152/ajpregu.00226.2004 (Pubitemid 39391072)
9. Z. Tatarková, S. Kuka, and P. Račay et al. Effects of aging on activities of mitochondrial electron transport chain complexes and oxidative damage in rat heart Physiol Res 60 2 2011 281 289 Available at, http://www.ncbi.nlm.nih.gov/pubmed/21114360 Accessed 24.03.14
10. S. Hauptmann, I. Scherping, and S. Dröse et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice Neurobiol Aging 30 10 2009 1574 1586 10.1016/j.neurobiolaging. 2007.12.005
11. D. Li, H. Chen, and A. Florentino et al. Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death Eukaryot Cell 10 5 2011 672 682 10.1128/EC.00303-10
12. E. Maranzana, G. Barbero, A.I. Falasca, G. Lenaz, and M.L. Genova Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I Antioxid Redox Signal 19 13 2013 1469 1480 10.1089/ars.2012.4845
13. T.T. Jones, and G.J. Brewer Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport Biochim Biophys Acta 1797 2 2010 167 176 10.1016/j.bbabio.2009.09.009
14. S. Papa, and D. De Rasmo Complex I deficiencies in neurological disorders Trends Mol Med 19 1 2013 61 69 10.1016/j.molmed.2012.11.005
15. J. Bereiter-Hahn Do we age because we have mitochondria? Protoplasma 251 1 2014 3 23 10.1007/s00709-013-0515-x
16. L. Bleier, and S. Dröse Superoxide generation by complex III: from mechanistic rationales to functional consequences Biochim Biophys Acta 11-12 1827 1320 1331 10.1016/j.bbabio.2012.12.002
17. R.J. Mailloux, X. Jin, and W.G. Willmore Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions Redox Biol 2 2013 123 139 10.1016/j.redox.2013.12.011
18. K. Leuner, S. Hauptmann, and R. Abdel-Kader et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 9 10 2007 1659 1675 10.1089/ars.2007.1763 (Pubitemid 47462969)
19. N. Kazachkova, A. Ramos, C. Santos, and M. Lima Mitochondrial DNA damage patterns and aging: revising the evidences for humans and mice Aging Dis 4 6 2013 337 350 10.14336/AD.2013.0400337
20. M. Frank, S. Duvezin-Caubet, and S. Koob et al. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner Biochim Biophys Acta 1823 12 2012 2297 2310 10.1016/j.bbamcr.2012.08.007
21. A. Barnett, and G.J. Brewer Autophagy in aging and Alzheimer's disease: pathologic or protective? J Alzheimers Dis 25 3 2011 385 394 10.3233/JAD-2011-101989
22. A. Eckert, R. Nisbet, A. Grimm, and J. Götz March separate, strike together - role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease Biochim Biophys Acta 1842 8 2013 1258 1266 10.1016/j.bbadis.2013.08.013
23. J.-H. Heo, Hyon-Lee, and K.M. Lee The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention Am J Alzheimers Dis Other Demen 28 2 2013 120 125 10.1177/1533317512473193
24. W.E. Müller, A. Eckert, C. Kurz, G.P. Eckert, and K. Leuner Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects Mol Neurobiol 41 2-3 2010 159 171 10.1007/s12035-010-8141-5
25. M.F. Beal Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment J Bioenerg Biomembr 36 4 2004 381 386 10.1023/B:JOBB.0000041772.74810.92 (Pubitemid 39619845)
26. R.K. Chaturvedi, and Beal M. Flint Mitochondrial diseases of the brain Free Radic Biol Med 63 2013 1 29 10.1016/j.freeradbiomed.2013.03.018
27. K. Leuner, T. Schütt, and C. Kurz et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation Antioxid Redox Signal 16 12 2012 1421 1433 10.1089/ars.2011.4173
28. R.H. Swerdlow, J.M. Burns, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis J Alzheimers Dis 20 Suppl 2 2010 S265 S279 10.3233/JAD-2010-100339
29. R.H. Swerdlow, J.M. Burns, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives Biochim Biophys Acta 1842 8 2014 1219 1231 10.1016/j.bbadis.2013.09.010
30. R.H. Swerdlow Alzheimer's disease pathologic cascades: who comes first, what drives what Neurotox Res 22 3 2012 182 194 10.1007/s12640-011-9272-9
31. T. Jiang, J.-T. Yu, Y. Tian, and L. Tan Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors Curr Alzheimer Res 10 8 2013 852 867 Available at, http://www.ncbi.nlm.nih.gov/pubmed/23919770 Accessed 16.01.14
32. H. Rhinn, R. Fujita, L. Qiang, R. Cheng, J.H. Lee, and A. Abeliovich Integrative genomics identifies APOE 4 effectors in Alzheimer's disease Nature 500 7460 2013 45 50 10.1038/nature12415
33. O. Liraz, A. Boehm-Cagan, and D.M. Michaelson ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice Mol Neurodegener 8 1 2013 16 10.1186/1750-1326-8-16
34. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat Rev Mol Cell Biol 8 2 2007 101 112 10.1038/nrm2101 (Pubitemid 46432529)
35. H.W. Querfurth, and F.M. Laferla Alzheimer's disease N Engl J Med 362 4 2013 329 344
36. G.E. Gibson, J.P. Blass, M.F. Beal, and V. Bunik The alpha-ketoglutarate- dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration Mol Neurobiol 31 1-3 2005 43 63 10.1385/MN:31:1-3:043 (Pubitemid 41271193)
37. S.J. Kish, C. Bergeron, and A. Rajput et al. Brain cytochrome oxidase in Alzheimer's disease J Neurochem 59 2 1992 776 779 Available at, http://www.ncbi.nlm.nih.gov/pubmed/1321237 Accessed 26.03.14
38. S.M. Cardoso, M.T. Proença, S. Santos, I. Santana, and C.R. Oliveira Cytochrome c oxidase is decreased in Alzheimer's disease platelets Neurobiol Aging 25 1 2004 105 110 Available at, http://www.ncbi.nlm.nih.gov/ pubmed/14675736 Accessed 26.03.14 (Pubitemid 37522198)
39. K.J. Krishnan, T.E. Ratnaike, H.L.M. De Gruyter, E. Jaros, and D.M. Turnbull Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease Neurobiol Aging 33 9 2012 2210 2214 10.1016/j. neurobiolaging.2011.08.009
40. L. Mosconi, M. de Leon, and J. Murray et al. Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease J Alzheimers Dis 27 3 2011 483 490 10.3233/JAD-2011-110866
41. A. Cheng, R. Wan, and J.-L. Yang et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines Nat Commun 3 2012 1250 10.1038/ncomms2238
42. D.F. Silva, J.E. Selfridge, and J. Lu et al. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines Hum Mol Genet 22 19 2013 3931 3946 10.1093/hmg/ddt247
43. B. Sheng, X. Wang, and B. Su et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease J Neurochem 120 3 2012 419 429 10.1111/j.1471-4159.2011.07581.x
44. S.S. Hardas, R. Sultana, and A.M. Clark et al. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain Redox Biol 1 1 2013 80 85 10.1016/j.redox.2013.01.002
45. R. Sultana, M. Perluigi, and Butterfield D. Allan Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain Free Radic Biol Med 62 2013 157 169 10.1016/j.freeradbiomed.2012.09.027
46. M.L. Selley, D.R. Close, and S.E. Stern The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease Neurobiol Aging 23 3 2002 383 388 Available at, http://www.ncbi.nlm.nih.gov/ pubmed/11959400 Accessed 27.03.14 (Pubitemid 34312021)
47. W. Völkel, T. Sicilia, and A. Pähler et al. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease Neurochem Int 48 8 2006 679 686 10.1016/j.neuint.2005.12.003
48. K. Schuessel, C. Frey, and C. Jourdan et al. Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice Free Radic Biol Med 40 5 2006 850 862 10.1016/j.freeradbiomed.2005.10.041 (Pubitemid 43327319)
49. D.L. Marcus, C. Thomas, and C. Rodriguez et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease Exp Neurol 150 1 1998 40 44 10.1006/exnr.1997.6750 (Pubitemid 28146421)
50. P.K. Mandal, M. Tripathi, and S. Sugunan Brain oxidative stress: detection and mapping of anti-oxidant marker "glutathione" in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy Biochem Biophys Res Commun 417 1 2012 43 48 10.1016/j.bbrc.2011.11.047
51. C.D. Aluise, R.A.S. Robinson, J. Cai, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI J Alzheimers Dis 23 2 2011 257 269 10.3233/JAD-2010-101083
52. L.L. Torres, N.B. Quaglio, and G.T. de Souza et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease J Alzheimers Dis 26 1 2011 59 68 10.3233/JAD-2011-110284
53. K. Leuner, W.E. Müller, and A.S. Reichert From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease Mol Neurobiol 46 1 2012 186 193 10.1007/s12035-012-8307-4
54. K. Leuner, K. Schulz, and T. Schütt et al. Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes Mol Neurobiol 46 1 2012 194 204 10.1007/s12035-012-8300-y
55. K. Schuessel, S. Schäfer, and T.A. Bayer et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice Neurobiol Dis 18 1 2005 89 99 10.1016/j.nbd.2004.09.003 (Pubitemid 40092899)
56. A. Eckert, S. Hauptmann, and I. Scherping et al. Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice J Mol Med (Berl) 86 11 2008 1255 1267 10.1007/s00109-008- 0391-6
57. V. Rhein, G. Baysang, and S. Rao et al. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells Cell Mol Neurobiol 29 6-7 2009 1063 1071 10.1007/s10571-009-9398-y
58. A. Bobba, G. Amadoro, D. Valenti, V. Corsetti, R. Lassandro, and A. Atlante Mitochondrial respiratory chain complexes I and IV are impaired by β-amyloid via direct interaction and through complex I-dependent ROS production, respectively Mitochondrion 13 4 2013 298 311 10.1016/j.mito.2013.03. 008
59. C.A. Hansson Petersen, N. Alikhani, and H. Behbahani et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proc Natl Acad Sci U S A 105 35 2008 13145 13150 10.1073/pnas.0806192105
60. A.D. Roses, M.W. Lutz, and H. Amrine-Madsen et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharmacogenomics J 10 5 2010 375 384 10.1038/tpj.2009.69
61. A.D. Roses, M.W. Lutz, D.G. Crenshaw, I. Grossman, A.M. Saunders, and W.K. Gottschalk TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial Alzheimers Dement 9 2 2013 132 136 10.1016/j.jalz.2012.10.009
62. L. Devi, B.M. Prabhu, D.F. Galati, N.G. Avadhani, and H.K. Anandatheerthavarada Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction J Neurosci 26 35 2006 9057 9068 10.1523/JNEUROSCI.1469-06.2006 (Pubitemid 44319397)
63. P.F. Pavlov, B. Wiehager, and J. Sakai et al. Mitochondrial γ-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein FASEB J 25 1 2011 78 88 10.1096/fj.10-157230
64. C.S. Casley, L. Canevari, J.M. Land, J.B. Clark, and M.A. Sharpe Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities J Neurochem 80 1 2002 91 100 Available at, http://www.ncbi.nlm.nih. gov/pubmed/11796747 Accessed 27.03.14 (Pubitemid 34614581)
65. N. Khalifat, N. Puff, M. Dliaa, and M.I. Angelova Amyloid-β and the failure to form mitochondrial cristae: a biomimetic study involving artificial membranes J Alzheimers Dis 28 1 2012 33 48 10.3233/JAD-2011-110389
66. R.X. Santos, S.C. Correia, and X. Wang et al. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease J Alzheimers Dis 20 Suppl 2 2010 S401 S412 10.3233/JAD-2010-100666
67. M. Manczak, and P.H. Reddy Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage Hum Mol Genet 21 11 2012 2538 2547 10.1093/hmg/dds072
68. B. Cho, S.Y. Choi, H.M. Cho, H.J. Kim, and W. Sun Physiological and pathological significance of mitochondrial fission in the nervous system Exp Neurobiol 22 3 2013 149 157
69. X. Wang, B. Su, and H. Lee et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease J Neurosci 29 28 2009 9090 9103 10.1523/JNEUROSCI.1357-09.2009
70. D.-H. Cho, T. Nakamura, and J. Fang et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury Science 324 5923 2009 102 105 10.1126/science.1171091
71. B. Bossy, A. Petrilli, and E. Klinglmayr et al. S-nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease J Alzheimers Dis 20 Suppl 2 2010 S513 S526 10.3233/JAD-2010-100552
72. M. Jendrach, S. Mai, S. Pohl, M. Vöth, and J. Bereiter-Hahn Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress Mitochondrion 8 4 2008 293 304 10.1016/j.mito.2008. 06.001
73. J. Riemer, and S. Kins Axonal transport and mitochondrial dysfunction in Alzheimer's disease Neurodegener Dis 12 3 2013 111 124 10.1159/000342020
74. H. Du, and S.S. Yan Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta Biochim Biophys Acta 1802 1 2010 198 204 10.1016/j.bbadis.2009.07.005
75. I.G. Gazaryan, and A.M. Brown Intersection between mitochondrial permeability pores and mitochondrial fusion/fission Neurochem Res 32 4-5 2007 917 929 10.1007/s11064-006-9252-2 (Pubitemid 46481317)
76. J. Piquereau, F. Caffin, and M. Novotova et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload Cardiovasc Res 94 3 2012 408 417 10.1093/cvr/cvs117
77. A.P. Halestrap What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46 6 2009 821 831 10.1016/j.yjmcc.2009.02.021
78. Y. Hou, P. Ghosh, and R. Wan et al. Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation Neurobiol Aging 35 5 2014 975 989 10.1016/j.neurobiolaging.2013.11.002
79. H. Du, L. Guo, and F. Fang et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease Nat Med 14 10 2008 1097 1105 10.1038/nm.1868
80. J.W. Lustbader, M. Cirilli, and C. Lin et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 5669 2004 448 452 10.1126/science.1091230 (Pubitemid 38495942)
81. J. Yao, H. Du, and S. Yan et al. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease J Neurosci 31 6 2011 2313 2320 10.1523/JNEUROSCI.4717-10.2011
82. E. Borger, L. Aitken, H. Du, W. Zhang, F.J. Gunn-Moore, and S.S. Du Yan Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr Alzheimer Res 10 1 2013 21 29 Available at, http://www. pubmedcentral.nih.gov/articlerender.fcgiartid=3674883&tool= pmcentrez&rendertype=abstract Accessed 13.05.14
83. D. Selkoe, E. Mandelkow, and D. Holtzman Deciphering Alzheimer disease Cold Spring Harb Perspect Med 2 1 2012 a011460 10.1101/cshperspect.a011460
84. E.-M. Mandelkow, and E. Mandelkow Biochemistry and cell biology of tau protein in neurofibrillary degeneration Cold Spring Harb Perspect Med 2 7 2012 a006247 10.1101/cshperspect.a006247
85. B. DuBoff, M. Feany, and J. Götz Why size matters - balancing mitochondrial dynamics in Alzheimer's disease Trends Neurosci 36 6 2013 325 335 10.1016/j.tins.2013.03.002
86. D.C. David, S. Hauptmann, and I. Scherping et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice J Biol Chem 280 25 2005 23802 23814 10.1074/jbc.M500356200 (Pubitemid 40884866)
87. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 106 34 2009 14670 14675 10.1073/pnas.0903563106
88. V. Rhein, X. Song, and A. Wiesner et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice Proc Natl Acad Sci U S A 106 47 2009 20057 20062 10.1073/pnas.0905529106
89. B. DuBoff, J. Götz, and M.B. Feany Tau promotes neurodegeneration via DRP1 mislocalization in vivo Neuron 75 4 2012 618 632 10.1016/j.neuron.2012. 06.026
90. K.L. Schulz, A. Eckert, and V. Rhein et al. A new link to mitochondrial impairment in tauopathies Mol Neurobiol 46 1 2012 205 216 10.1007/s12035-012- 8308-3
91. K. Iijima-Ando, M. Sekiya, and A. Maruko-Otake et al. Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1 PLoS Genet 8 8 2012 e1002918 10.1371/journal.pgen.1002918
92. P.H. Reddy Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease Brain Res 1415 2011 136 148 10.1016/j.brainres.2011.07.052
93. E. Tamagno, M. Guglielmotto, D. Monteleone, and M. Tabaton Amyloid-β production: major link between oxidative stress and BACE1 Neurotox Res 22 3 2012 208 219 10.1007/s12640-011-9283-6
94. M. Guglielmotto, M. Aragno, and R. Autelli et al. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha J Neurochem 108 4 2009 1045 1056 10.1111/j.1471-4159.2008.05858.x
95. L. Chen, S.-E. Yoo, R. Na, Y. Liu, and Q. Ran Cognitive impairment and increased Aβ levels induced by paraquat exposure are attenuated by enhanced removal of mitochondrial H(2)O(2) Neurobiol Aging 33 2 2012 432.e15 432.e26 10.1016/j.neurobiolaging.2011.01.008
96. J.E. Morley, H.J. Armbrecht, S.A. Farr, and V.B. Kumar The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease Biochim Biophys Acta 1822 5 2012 650 656 10.1016/j.bbadis.2011.11.015
97. D. Orsucci, M. Mancuso, E.C. Ienco, C. Simoncini, G. Siciliano, and U. Bonuccelli Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease Curr Neurovasc Res 10 1 2013 76 80 Available at, http://www.ncbi.nlm.nih.gov/pubmed/23151073 Accessed 21.03.14
98. S. Shiota, H. Takekawa, and S.-E. Matsumoto et al. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice J Alzheimers Dis 37 2 2013 325 333 10.3233/JAD-130419
99. L. Gao, S. Tian, H. Gao, and Y. Xu Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice J Mol Neurosci 51 1 2013 138 147 10.1007/s12031-013-9966-y
100. C.R. Jack, D.S. Knopman, and W.J. Jagust et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 1 2010 119 128 10.1016/S1474-4422(09)70299-6
101. C. Reitz, C. Brayne, and R. Mayeux Epidemiology of Alzheimer disease Nat Rev Neurol 7 3 2011 137 152 10.1038/nrneurol.2011.2
102. E. Hellström-Lindahl, R. Ravid, and A. Nordberg Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels Neurobiol Aging 29 2 2008 210 221 10.1016/j.neurobiolaging.2006.10.010
103. E. Hellström-Lindahl, M. Viitanen, and A. Marutle Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease Neurochem Int 55 4 2009 243 252 10.1016/j.neuint.2009.03.007
104. M. Morishima-Kawashima, N. Oshima, and H. Ogata et al. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain Am J Pathol 157 6 2000 2093 2099
105. H. Funato, M. Yoshimura, and K. Kusui et al. Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease Am J Pathol 152 6 1998 1633 1640 (Pubitemid 28275021)
106. S.E. Lesné Breaking the code of amyloid-β oligomers Int J Cell Biol 2013 2013 950783 10.1155/2013/950783
107. G.D. Silverberg, M.C. Miller, and A.A. Messier et al. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging J Neuropathol Exp Neurol 69 1 2010 98 108 10.1097/NEN.0b013e3181c8ad2f
108. C. Chiu, M.C. Miller, and I.N. Caralopoulos et al. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months Fluids Barriers CNS 9 1 2012 3 10.1186/2045-8118-9-3
109. U. Keil, A. Bonert, and C.A. Marques et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis J Biol Chem 279 48 2004 50310 50320 10.1074/jbc.M405600200 (Pubitemid 39577847)
110. K. Schmitt, A. Grimm, A. Kazmierczak, J.B. Strosznajder, J. Götz, and A. Eckert Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio Antioxid Redox Signal 16 12 2012 1456 1466 10.1089/ars.2011.4400
111. J. Eckmann, S.H. Eckert, K. Leuner, W.E. Muller, and G.P. Eckert Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration Int J Biochem Cell Biol 45 1 2013 76 80 10.1016/j.biocel.2012.06.009
112. C. Stockburger, C. Kurz, K.A. Koch, S.H. Eckert, K. Leuner, and W.E. Müller Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam Biochem Soc Trans 41 5 2013 1331 1334 10.1042/BST20130054
113. M.-Y. Cha, S.-H. Han, and S.M. Son et al. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death PLoS One 7 4 2012 e34929 10.1371/journal.pone.0034929
114. M. Manczak, P. Mao, and M.J. Calkins et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons J Alzheimers Dis 20 Suppl. 2 2010 S609 S631 10.3233/JAD-2010-100564
115. S.J. Baloyannis, V. Costa, and D. Michmizos Mitochondrial alterations in Alzheimer's disease Am J Alzheimers Dis Other Demen 19 2 2004 89 93 (Pubitemid 38495952)
116. G. Bu Apolipoprotein E, and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nat Rev Neurosci 10 5 2009 333 344 10.1038/nrn2620
117. C.-C. Liu, C.-C. Liu, T. Kanekiyo, H. Xu, and G. Bu Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Nat Rev Neurol 9 2 2013 106 118 10.1038/nrneurol.2012.263
118. H.-K. Chen, Z.-S. Ji, and S.E. Dodson et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease J Biol Chem 286 7 2011 5215 5221 10.1074/jbc.M110.151084
119. T. Nakamura, A. Watanabe, T. Fujino, T. Hosono, and M. Michikawa Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells Mol Neurodegener 4 2009 35 10.1186/1750-1326-4-35
120. L. Fang Ng, J. Gruber, and I. Cheah et al. The mitochondria-targeted antioxidant MitoQ extends life span and improves health span of a transgenic Caenorhabditis elegans model of Alzheimer disease Free Radic Biol Med 71C 2014 390 401 10.1016/j.freeradbiomed.2014.03.003
121. P. Mao, M. Manczak, U.P. Shirendeb, and P.H. Reddy MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis Biochim Biophys Acta 1832 12 2013 2322 2331 10.1016/j.bbadis.2013.09.005
122. M.J. McManus, M.P. Murphy, and J.L. Franklin The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease J Neurosci 31 44 2011 15703 15715 10.1523/JNEUROSCI.0552-11.2011
123. M. Dumont, K. Kipiani, and F. Yu et al. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease J Alzheimers Dis 27 1 2011 211 223 10.3233/JAD-2011-110209
124. H. Choi, H.-H. Park, and K.-Y. Lee et al. Coenzyme Q10 restores amyloid beta-inhibited proliferation of neural stem cells by activating the PI3K pathway Stem Cells Dev 22 15 2013 2112 2120 10.1089/scd.2012.0604
125. D.R. Galasko, E. Peskind, and C.M. Clark et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures Arch Neurol 69 7 2012 836 841 10.1001/archneurol.2012.85
126. J. Sastre, A. Lloret, and C. Borrás et al. Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver Cell Mol Biol (Noisy-le-Grand) 48 6 2002 685 692 Available at, http://www.ncbi.nlm. nih.gov/pubmed/12396080 Accessed 21.03.14
127. R. Abdel-Kader, S. Hauptmann, and U. Keil et al. Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761) Pharmacol Res 56 6 2007 493 502 10.1016/j.phrs.2007.09.011 (Pubitemid 350148165)
128. V. Rhein, M. Giese, and G. Baysang et al. Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure PLoS One 5 8 2010 e12359 10.1371/journal.pone.0012359
129. Y. Luo Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract Life Sci 78 18 2006 2066 2072 10.1016/j.lfs.2005.12. 004
130. J.V. Smith, and Y. Luo Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761 J Alzheimers Dis 5 4 2003 287 300 Available at, http://www.ncbi.nlm.nih.gov/ pubmed/14624024 Accessed 28.03.14 (Pubitemid 37411776)
131. A.J. Kellermann, and C. Kloft Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis Pharmacotherapy 31 5 2011 490 502 10.1592/phco.31.5.490
132. Y. Wu, Z. Wu, and P. Butko et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans J Neurosci 26 50 2006 13102 13113 10.1523/JNEUROSCI.3448-06.2006 (Pubitemid 44954628)
133. S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth, and S.N. Willich Effects of Ginkgo biloba in dementia: systematic review and meta-analysis BMC Geriatr 10 2010 14 10.1186/1471-2318-10-14
134. C. Kurz, I. Ungerer, and U. Lipka et al. The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide Br J Pharmacol 160 2 2010 246 257 10.1111/j.1476-5381.2010.00656.x
135. U. Keil, I. Scherping, S. Hauptmann, K. Schuessel, A. Eckert, and W.E. Müller Piracetam improves mitochondrial dysfunction following oxidative stress Br J Pharmacol 147 2 2006 199 208 10.1038/sj.bjp.0706459 (Pubitemid 43151568)
136. T. Waegemans, C.R. Wilsher, A. Danniau, S.H. Ferris, A. Kurz, and B. Winblad Clinical efficacy of piracetam in cognitive impairment: a meta-analysis Dement Geriatr Cogn Disord 13 4 2002 217 224 10.1159/000057700 (Pubitemid 34507607)
137. J.W. Steele, M.L. Lachenmayer, and S. Ju et al. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model Mol Psychiatry 18 8 2013 889 897 10.1038/mp.2012.106
138. O.M. Peters, T. Shelkovnikova, and T. Tarasova et al. Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice J Alzheimers Dis 36 3 2013 589 596 10.3233/JAD-130071
139. N. Cano-Cuenca, J.E. Solís-García del Pozo, and J. Jordán Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis J Alzheimers Dis 38 1 2014 155 164
140. S.H. Eckert, J. Eckmann, K. Renner, G.P. Eckert, K. Leuner, and W.E. Muller Dimebon ameliorates amyloid-β induced impairments of mitochondrial form and function J Alzheimers Dis 31 1 2012 21 32 10.3233/JAD-2012-120310
141. O.M. Peters, N. Connor-Robson, and V.B. Sokolov et al. Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice J Alzheimers Dis 33 4 2013 1041 1049 10.3233/JAD-2012-121732
142. R.S. Doody, S.I. Gavrilova, and M. Sano et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study Lancet 372 9634 2008 207 215 10.1016/S0140-6736(08) 61074-0 (Pubitemid 351978110)
143. I. Bezprozvanny The rise and fall of Dimebon Drug News Perspect 23 8 2010 518 523 10.1358/dnp.2010.23.8.1500435
144. N. Farina, M.G.E.K.N. Isaac, A.R. Clark, J. Rusted, and N. Tabet Vitamin E for Alzheimer's dementia and mild cognitive impairment Cochrane Database Syst Rev 11 2012 CD002854 10.1002/14651858.CD002854.pub3
145. R.J. Williams, and J.P.E. Spencer Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease Free Radic Biol Med 52 1 2012 35 45 10.1016/j.freeradbiomed.2011.09.010
146. D.-Y. Choi, Y.-J. Lee, J.T. Hong, and H.-J. Lee Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease Brain Res Bull 87 2-3 2012 144 153 10.1016/j.brainresbull.2011.11.014
147. A.S. Darvesh, R.T. Carroll, A. Bishayee, W.J. Geldenhuys, and C.J. Van der Schyf Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents Expert Rev Neurother 10 5 2010 729 745 10.1586/ern.10.42
148. N. Scarmeas Mediterranean food for thought? J Neurol Neurosurg Psychiatry 84 12 2013 1297 10.1136/jnnp-2013-305153
149. G.P. Eckert, K. Renner, and S.H. Eckert et al. Mitochondrial dysfunction - a pharmacological target in Alzheimer's disease Mol Neurobiol 46 1 2012 136 150 10.1007/s12035-012-8271-z
150. A. Hofer, N. Noe, and C. Tischner et al. Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo Hum Mol Genet 23 9 2014 2400 2415 10.1093/hmg/ddt631
151. D. Jat, P. Parihar, S.C. Kothari, and M.S. Parihar Curcumin reduces oxidative damage by increasing reduced glutathione and preventing membrane permeability transition in isolated brain mitochondria Cell Mol Biol (Noisy-le-Grand) 59 Suppl 2013 OL1899 OL1905 Available at, http://www.ncbi.nlm. nih.gov/pubmed/24461330 Accessed 13.05.14
152. W.-H. Lee, C.-Y. Loo, M. Bebawy, F. Luk, R.S. Mason, and R. Rohanizadeh Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century Curr Neuropharmacol 11 4 2013 338 378 10.2174/1570159X11311040002
153. H.V. Kim, H.Y. Kim, H.Y. Ehrlich, S.Y. Choi, D.J. Kim, and Y. Kim Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model Amyloid 20 1 2013 7 12 10.3109/13506129.2012.751367
154. A. Eckert, U. Keil, I. Scherping, S. Hauptmann, and W.E. Müller Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761 Ann N Y Acad Sci 1056 2005 474 485 10.1196/annals.1352.023 (Pubitemid 43031000)
155. K. Schindowski, S. Leutner, S. Kressmann, A. Eckert, and W.E. Müller Age-related increase of oxidative stress-induced apoptosis in mice prevention by Ginkgo biloba extract (EGb761) J Neural Transm 108 8-9 2001 969 978 Available at, http://www.ncbi.nlm.nih.gov/pubmed/11716149 Accessed 21.03.14 (Pubitemid 32802094)
156. K. Leuner, C. Kurz, G. Guidetti, J.M. Orgogozo, and W.E. Müller Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam Front Neurosci 4 44 2010 1 11 10.3389/fnins.2010.00044
157. S.E. Perez, M. Nadeem, and K.R. Sadleir et al. Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice Int J Physiol Pathophysiol Pharmacol 4 3 2012 115 127 Available at, http://www.pubmedcentral.nih.gov/articlerender.fcgiartid= 3466490&tool=pmcentrez&rendertype=abstract Accessed 31.03.14
158. K.K. Naga, and J.W. Geddes Dimebon inhibits calcium-induced swelling of rat brain mitochondria but does not alter calcium retention or cytochrome c release Neuromolecular Med 13 1 2011 31 36 10.1007/s12017-010-8130-x
159. E.F. Shevtsova, D.V. Vinogradova, E.G. Kireeva, V.P. Reddy, G. Aliev, and S.O. Bachurin Dimebon attenuates the Aβ-induced mitochondrial permeabilization Curr Alzheimer Res 2014 Available at, http://www.ncbi.nlm.nih. gov/pubmed/24801220 Accessed 12.05.14
160. R. James, J.L. Searcy, and T. Le Bihan et al. Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge J Cereb Blood Flow Metab 32 1 2012 164 176 10.1038/jcbfm.2011.120